Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX)

Q: What does CUSIP 055477103 represent in this 13F holders report?

CUSIP 055477103 is the security identifier for BCAX - Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held BCAX - Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share in Q4 2025?

140 institutional investors reported BCAX - Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share for Q4 2025. Use the holders table for investor-level position and value details.

CUSIP: 055477103

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 65,361,446
Total 13F shares: 57,096,017
Share change: +6,913,932
Total reported value: $960,809,333
Price per share: $16.83
Number of holders: 140
Value change: +$119,906,754
Number of buys: 88
Number of sells: 51

Quarterly Holders Quick Answers

What is CUSIP 055477103?
CUSIP 055477103 identifies BCAX - Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2026
Previous quarter: Q3 2025

Recent filing periods for CUSIP 055477103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024

Top shareholders of BCAX - Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RA CAPITAL MANAGEMENT, L.P.	13F	Company	11%	6,955,993	$109,835,129	—	30 Sep 2025	13F
Kiran Mazumdar-Shaw	3/4/5	Director, 10%+ Owner	— mixed-class rows	6,304,931 mixed-class rows	$83,184,246	—	09 Jun 2025	3/4/5
Siren, L.L.C.	13F	Individual	8%	5,216,969	$82,375,941	—	30 Sep 2025	13F
Vestal Point Capital, LP	13F	Company	7.8%	5,100,000	$80,529,000	—	30 Sep 2025	13F
Biocon Ltd	3/4/5	10%+ Owner	— class O/S missing	5,523,897	$73,155,178	—	16 Sep 2024	3/4/5
Invus Global Management, LLC	13D/G	Raymond Debbane	9.6%	5,216,969	$50,656,769	$0	30 Jun 2025	13D/G
Red Tree Management, LLC	13F	Company	4.9%	3,170,509	$50,062,337	—	30 Sep 2025	13F
TPG GP A, LLC	13F 3/4/5	Company · Former 10% Owner	4.6%	3,010,425	$47,534,611	—	30 Sep 2025	13F 3/4/5
FMR LLC	13F 3/4/5	Company · Other*	4.1%	2,698,361	$42,607,120	—	30 Sep 2025	13F 3/4/5
Deep Track Capital, LP	13F	Company	3.7%	2,426,657	$38,316,914	—	30 Sep 2025	13F
BlackRock, Inc.	13F	Company	3.5%	2,311,789	$36,503,145	—	30 Sep 2025	13F
Omega Fund Management, LLC	13F	Company	3.4%	2,204,650	$34,811,424	—	30 Sep 2025	13F
VANGUARD GROUP INC	13F	Company	3.4%	2,200,925	$34,752,606	—	30 Sep 2025	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	2.7%	1,755,411	$27,719,000	—	30 Sep 2025	13F
James E. Flynn	3/4/5	Possible Members of 10% Group, 10%+ Owner	— class O/S missing	1,795,174	$23,774,208	—	17 Sep 2024	3/4/5
Blackstone Inc.	13F	Company	1.9%	1,224,336	$19,332,265	—	30 Sep 2025	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.6%	1,014,892	$16,025,145	—	30 Sep 2025	13F
FIL Ltd	3/4/5 13F	Other* · Company	1.2% from 13F	1,013,853	$13,426,861	—	16 Sep 2024	3/4/5 13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.3%	831,208	$13,127,637	—	30 Sep 2025	13F
ACORN CAPITAL ADVISORS, LLC	13F	Company	0.98%	643,382	$10,158,996	—	30 Sep 2025	13F
STATE STREET CORP	13F	Company	0.9%	590,277	$9,320,474	—	30 Sep 2025	13F
Aisling Capital Management LP	13F	Company	0.87%	568,919	$8,983,231	—	30 Sep 2025	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.77%	504,085	$7,959,499	—	30 Sep 2025	13F
T. Rowe Price Investment Management, Inc.	13F	Company	0.71%	464,727	$7,339,000	—	30 Sep 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.7%	456,621	$7,210,046	—	30 Sep 2025	13F
NAN FUNG TRINITY (HK) Ltd	13F	Company	0.59%	384,885	$6,077,334	—	30 Sep 2025	13F
Rock Springs Capital Management LP	13F	Company	0.57%	370,666	$5,852,816	—	30 Sep 2025	13F
Woodline Partners LP	13F	Company	0.53%	348,690	$5,505,815	—	30 Sep 2025	13F
Clearbridge Investments, LLC	13F	Company	0.5%	324,321	$5,121,029	—	30 Sep 2025	13F
DAFNA Capital Management LLC	13F	Company	0.48%	317,001	$5,005,446	—	30 Sep 2025	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.43%	280,876	$4,435,032	—	30 Sep 2025	13F
Napean Trading & Investment Co (Singapore) PTE Ltd	13F	Company	0.42%	275,942	$4,357,124	—	30 Sep 2025	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.41%	266,495	$4,207,956	—	30 Sep 2025	13F
NORTHERN TRUST CORP	13F	Company	0.4%	260,866	$4,119,075	—	30 Sep 2025	13F
SILVERARC CAPITAL MANAGEMENT, LLC	13F	Company	0.38%	250,606	$3,957,069	—	30 Sep 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.36%	232,761	$3,675,296	—	30 Sep 2025	13F
TD ASSET MANAGEMENT INC	13F	Company	0.28%	184,982	$2,920,866	—	30 Sep 2025	13F
SUPERSTRING CAPITAL MANAGEMENT LP	13F	Company	0.27%	175,902	$2,777,493	—	30 Sep 2025	13F
SCHRODER INVESTMENT MANAGEMENT GROUP	13F	Company	0.27%	173,651	$2,408,539	—	30 Sep 2025	13F
DEUTSCHE BANK AG\	13F	Company	0.2%	127,455	$2,012,514	—	30 Sep 2025	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.19%	126,802	$2,002,204	—	30 Sep 2025	13F
MARSHALL WACE, LLP	13F	Company	0.17%	112,086	$1,769,838	—	30 Sep 2025	13F
MORGAN STANLEY	13F	Company	0.15%	100,028	$1,579,442	—	30 Sep 2025	13F
CANTOR FITZGERALD, L. P.	13F	Individual	0.15%	100,000	$1,579,000	—	30 Sep 2025	13F
UBS Group AG	13F	Company	0.15%	97,362	$1,537,346	—	30 Sep 2025	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.15%	95,238	$1,503,808	—	30 Sep 2025	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.13%	85,747	$1,353,945	—	30 Sep 2025	13F
Bank of New York Mellon Corp	13F	Company	0.13%	84,534	$1,334,792	—	30 Sep 2025	13F
RAYMOND JAMES FINANCIAL INC	13F	Company	0.1%	67,701	$1,068,998	—	30 Sep 2025	13F
Mariner, LLC	13F	Company	0.1%	62,660	$989,401	—	30 Sep 2025	13F

Institutional Holders of Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX) as of Q4 2025

As of 31 Dec 2025, Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX) was held by 140 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 57,096,017 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., Siren, L.L.C., Vestal Point Capital, LP, FMR LLC, T. Rowe Price Investment Management, Inc., RED TREE MANAGEMENT, LLC, TPG GP A, LLC, JANUS HENDERSON GROUP PLC, Deep Track Capital, LP, and BlackRock, Inc.. This page lists 140 institutional shareholders reporting positions in this security for the Q4 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders

112

Q4 2025 holders

140

Holder diff

Investor	Q3 2025 Shares	Q4 2025 Shares	Share Diff	Share Chg %	Q3 2025 Value $	Q4 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.